JY
BIOA

Jeff Yass’s BioAge Labs BIOA Stock Holding History

Jeff Yass’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
58,400
-19,300
-25% -$349K ﹤0.01% 7277
2026
Q1 		$1.36M Buy
+77,700
New +$1.5M ﹤0.01% 7133
2025
Q4 		– Sell
-127,800
Closed -$751K – 13864
2025
Q3 		$751K Sell
127,800
-16,600
-11% -$77.7K ﹤0.01% 8019
2025
Q2 		$596K Buy
144,400
+61,800
+75% +$249K ﹤0.01% 8776
2025
Q1 		$311K Buy
+82,600
New +$382K ﹤0.01% 10000

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jeff Yass's BIOA Position: Q2 2026 in Review

Jeff Yass reduced its BioAge Labs (BIOA) stake by 3.4% in Q2 2026, selling an estimated $37.3K and leaving 58,025 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #7286.

Jeff Yass first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Jeff Yass held 58,025 shares of BioAge Labs worth $1.42M as of Q2 2026.
  • Jeff Yass sold 2,064 BioAge Labs shares in Q2 2026, an estimated $37.3K.
  • BioAge Labs made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7286 holding.
  • Jeff Yass first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.